RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• The C-type lectin receptor Clec9A is crucial for processing dead cell antigens for cross-presentation.
• Effective cross-presentation by dendritic cells is essential for initiating CD8+ T cell immunity.

Purpose of the Study:

• To investigate the regulatory mechanisms governing Clec9A function in antigen cross-presentation.
• To define the role of E3 ubiquitin ligase RNF41 in Clec9A-mediated immune responses.

Main Methods:

• Utilized mouse dendritic cells to study Clec9A regulation.
• Investigated the interaction between RNF41 and Clec9A.
• Analyzed the ubiquitination status and cellular localization of Clec9A.

Main Results:

• RNF41 acts as a negative regulator of Clec9A and antigen cross-presentation.
• RNF41 directly binds and ubiquitinates the extracellular domains of Clec9A.
• RNF41-mediated ubiquitination targets Clec9A for degradation via ER-associated pathways at steady-state.
• Clec9A interactions are modulated upon dead cell uptake to promote antigen presentation.

Conclusions:

• A novel ubiquitin-mediated mechanism regulates Clec9A stability and function.
• RNF41 controls Clec9A levels and antigen cross-presentation efficiency.
• Findings provide insights into modulating immune responses for therapeutic applications.